This month, the December 2012 issue of the Open Rheumatology Journal published an online article from a group that was brought together for a meeting in Aachen, Germany by GrĂ¼nenthal GmbH, a pharmaceutical company. The authors were compensated for their time and had assistance in the writing of the publication, which was funded by GrĂ¼nenthal.
The article describes osteoarthritis and rheumatoid arthritis, as well as multiple therapies. It concludes that the use of combinations of medications, as well as a multimechanistic approach are what is needed to help avoid the long-term potential safety concerns associated with NSAIDs.